Flaxseed supplementation improves anthropometric measurements, metabolic, and inflammatory biomarkers in overweight and obese adults
Abstract
Abstract.Background: The aim of this study was to assess the effects of supplementation with flaxseed on anthropometric measurements, lipid profile, insulin resistance, and inflammatory biomarkers in overweight and obese adults.
Methods: Fifty overweight and obese adults with body mass index (BMI) of 30.72 ± 3.31 kg/m2 participated in this study. Participants were randomly assigned to take lifestyle advice or lifestyle advice plus 30 g/day milled flaxseed for 12 weeks. The primary outcome was body weight; secondary outcomes included other anthropometric parameters, lipid profile and inflammatory biomarkers.
Results: At the end of the study, the following significant mean differences were seen in flaxseed and control groups, respectively: weight [−9.36 vs. −3.09 kg; P < 0.001], BMI [−3.34 vs. −1.2 kg/m2; P < 0.001], triglycerides [−62.88 vs. −9.85 mg/dL; P < 0.001], total cholesterol [−32.2 vs. −14.95 mg/dL; P = 0.04], homeostatic model assessment (HOMA-IR) [1.25 vs. −0.32; P = 0.024], high sensitive- C reactive protein [−2.2 vs. −1.01 mmol/L; P < 0.001] and tumor necrosis factor-α [−1.34 vs. −0.14 pg/mL; P = 0.005].
Conclusion: These results suggest that flaxseed supplementation in addition to lifestyle modification is significantly superior to lifestyle modification alone for weight loss. More studies with different dosages of flaxseed are needed to find the optimal dosage. This trial was registered at clinicaltrials.gov as NCT02410668.
References
1 (2003) Overweight and obesity worldwide now estimated to involve 1.7 billion people. Obesity Surgery. 13(3), 329–330.
2 (2014) Obesity, metabolic syndrome, and dietary therapeutical approaches with a special focus on nutraceuticals (polyphenols): A mini-review. Int J Vitam Nutr Res. 84(3–4), 113–23.
3 (2000) Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. Obesity Research, 49–61.
4 (2006) Barriers to obesity management: a pilot study of primary care clinicians. BMC Family Practice. 7(1), 35.
5 (2015) Association of major dietary patterns with general and abdominal obesity in iranian patients with type 2 diabetes mellitus. Int J Vitam Nutr Res. 85(3–4), 145–55.
6 (2004) Dietary fat and obesity: a review of animal, clinical and epidemiological studies. Physiology & Behavior. 83(4), 549–555.
7 (2013) Dietary supplementation with long chain omega-3 polyunsaturated fatty acids and weight loss in obese adults. Obes Res Clin Pract. 7(3), e173–e181.
8 (2000) Nutrition and the health care agenda: a primary care perspective. Family Practice. 17(2), 197–202.
9 (2010) Dietary fiber supplements: effects in obesity and metabolic syndrome and relationship to gastrointestinal functions. Gastroenterology. 138(1), 65–72. e2.
10 (1988) Obesity management via diet and exercise intervention. Child: Care, Health and Development. 14(6), 409–416.
11 (2007) flax - A Health and Nutrition Primer. (4 ed.).
12 (2014) Flax and flaxseed oil: an ancient medicine & modern functional food. Journal of Food Science and Technology. 51(9), 1633–1653.
13 (2013) Evaluation of the influence of whole and defatted flaxseed on satiety, glucose, and leptin levels of women in the late postoperative stage of bariatric surgery. Obesity Surgery. 23(2), 157–166.
14 (2010) Flaxseed lignan lowers blood cholesterol and decreases liver disease risk factors in moderately hypercholesterolemic men. Nutr Res. 30(7), 441–6.
15 (2008) Alpha-linolenic acid-rich flaxseed oil ingestion increases plasma adiponectin level in rats. Int J Vitam Nutr Res. 78(4–5), 223–9.
16 (2010) Effects of omega-3 supplementation in combination with diet and exercise on weight loss and body composition. AJCN. ajcn. 002741
17 (2015) Effects of brown and golden flaxseed on the lipid profile, glycemia, inflammatory biomarkers, blood pressure and body composition in overweight adolescents. Nutrition. 31(1), 90–96.
18 (2012) Omega 3 polyunsaturated fatty acids and body weight. BJN. 107(S2), S107–S116.
19 (2011) Effects of dietary fibre on subjective appetite, energy intake and body weight: a systematic review of randomized controlled trials. Obesity Reviews. 12(9), 724–739.
20 (2010) Usefulness of flaxseed oil in the limitation of diet induced metabolic disturbances. Roczniki Panstwowego Zakladu Higieny. 62(2), 215–218.
21 (2012) Unsaturated fatty acids revert diet-induced hypothalamic inflammation in obesity. PloS One. 7(1), e30571.
22 (2007) Systemic inflammation in morbidly obese subjects: response to oral supplementation with alpha-linolenic acid. Obesity Surgery. 17(3), 341–347.
23 (2012) Potential effects of lignan-enriched flaxseed powder on bodyweight, visceral fat, lipid profile, and blood pressure in rats. Fitoterapia. 83(5), 941–946.
24 (2000) The practical guide: identification, evaluation, and treatment of overweight and obesity in adults. National Heart: National Institutes of Health, National Heart, Lung, and Blood Institute, NHLBI Obesity Education Initiative, North American Association for the Study of Obesity.
25 (2001) Assessment of physical activity of adolescents in Isfahan. Shahrekord University of Medical Sciences Journal. 3(2), 55–66.
26 (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28(7), 412–419.
27 (1999) The manual for household measures, cooking yields factors and edible portion of foods. pp. 1–40, Nashre Olume Keshavarzy, Tehran.
28 (2013) Linseed dietary fibers reduce apparent digestibility of energy and fat and weight gain in growing rats. Nutrients. 5(8), 3287–3298.
29 (2012) Dietary flaxseed oil reduces adipocyte size, adipose monocyte chemoattractant protein-1 levels and T-cell infiltration in obese, insulin-resistant rats. Cytokine. 59(2), 382–91.
30 (2012) Flaxseed lignan complex administration in older human type 2 diabetics manages central obesity and prothrombosis-an invitation to further investigation into polypharmacy reduction. J Nutr Metab. 2012, 585170.
31 (2013) Effects of flaxseed supplementation on erythrocyte fatty acids and multiple cardiometabolic biomarkers among Chinese with risk factors of metabolic syndrome. Eur J Nutr. 52(5), 1547–51.
32 (2008) Low n-6:n-3 fatty acid ratio, with fish- or flaxseed oil, in a high fat diet improves plasma lipids and beneficially alters tissue fatty acid composition in mice. Eur J Nutr. 47(3), 153–60.
33 (1997) Dietary fiber decreases the metabolizable energy content and nutrient digestibility of mixed diets fed to humans. The Journal of Nutrition. 127(4), 579–586.
34 (2001) Dietary fiber and body-weight regulation: observations and mechanisms. Pediatric Clinics of North America. 48(4), 969–980.
35 (2007) Metabolic syndrome is associated with adherence to an unhealthy diet. Diabetes Care. 30(9), e93.
36 (2011) Dietary fatty acid composition and metabolic syndrome in Tehranian adults. Nutrition. 27(10), 1002–7.
37 (2012) Is There a Place for Dietary Fiber Supplements in Weight Management? Current Obesity Reports. 1(2), 59–67.
38 (2013) et al.Flaxseed dietary fibers suppress postprandial lipemia and appetite sensation in young men. Nutrition, Metabolism and Cardiovascular Diseases. 23(2), 136–143.
39 (2004) Peroxisome proliferator-activated receptors and atherogenesis regulators of gene expression in vascular cells. Circulation Research. 94(9), 1168–1178.
40 (2008) Whole flaxseeds but not sunflower seeds in rye bread reduce apparent digestibility of fat in healthy volunteers. Eur J Clin Nutr. 62(8), 961–967.
41 (2014) The anti-atherogenic properties of sesamin are mediated via improved macrophage cholesterol efflux through PPARgamma1-LXRalpha and MAPK signaling. Int J Vitam Nutr Res. 84(1–2), 79–91.
42 (2014) Anti-hyperglycemic and insulin sensitizer effects of turmeric and its principle constituent curcumin. Int J Endocrinol Metab. 12(4), e18081.
43 (2015) Impact of weight loss diet associated with flaxseed on inflammatory markers in men with cardiovascular risk factors: a clinical study. Nutrition Journal. 14(1), 5.
44 (2015) The relationship between body weight and inflammation: Lesson from anti-TNF-alpha antibody therapy. Hum Immunol, S0198–8859.
45 (2014) Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study. Br J Nutr. 112(3), 438–45.
46 (2013) Daily flaxseed consumption improves glycemic control in obese men and women with pre-diabetes: a randomized study. Nutr Res. 33(5), 367–75.